- Condition: Postoperative Delirium
Intervention: Other: Bedside Mirrors Intervention
Sponsors: Papworth Hospital NHS Foundation Trust; Papworth Hospital NHS Foundation Trust
Not yet recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: E2609; Drug: Placebo
Sponsors: Eisai Inc.; Eisai Inc.
Not yet recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Lipitor; Drug: placebo
Sponsors: University of Pennsylvania; University of Pennsylvania
Not yet recruiting - verified May 2012 - Conditions: Encephalopathy, Hepatic; Cerebrovascular Disorders; Liver Failure
Intervention: Other: No interventions
Sponsors: Johannes Gutenberg University Mainz; Johannes Gutenberg University Mainz
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment; Spinal Cord Injuries
Intervention: Drug: oxybutynin, tolterodine
Sponsors: Swiss Paraplegic Centre Nottwil; Swiss Paraplegic Centre Nottwil
Recruiting - verified May 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment
Interventions: Drug: saline; Drug: insulin detemir; Drug: Insulin
Sponsors: University of Washington; University of Washington; Alzheimer's Association
Recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate; Drug: Long acting methylphenidate; Drug: Matched placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified May 2012 - Conditions: Traumatic Brain Injury; Cognitive Dysfunction; Blast Injury
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS), MagStim; Behavioral: Cognitive Intervention
Sponsors: Boston Medical Center; Boston Medical Center; National Center for Research Resources (NCRR)
Not yet recruiting - verified May 2012 - Conditions: Cognition Disorders; Cocaine Dependence; ADHD
Intervention: Procedure: repetitive Transcranial Magnetic Stimulation (rTMS)
Sponsors: University of Sao Paulo General Hospital; University of Sao Paulo General Hospital
Recruiting - verified May 2012 - Condition: Cognitive Impairment
Intervention: Dietary Supplement: green tea powder
Sponsors: University of Shizuoka; University of Shizuoka
Not yet recruiting - verified April 2012 - Conditions: Aging; Mild Cognitive Impairment; Angina Pectoris
Intervention:
Sponsors: Korea Institute of Oriental Medicine; Korea Institute of Oriental Medicine; Dunsan Oriental Medical Hospital of Daejeon University
Recruiting - verified May 2012 - Conditions: Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Adrenoleukodystrophy; Niemann-Pick Disease; Metachromatic Leukodystrophy; Wolman Disease; Krabbe's Disease; Gaucher's Disease; Fucosidosis; Batten Disease; Severe Aplastic Anemia; Diamond-Blackfan Anemia; Amegakaryocytic Thrombocytopenia; Myelodysplastic Syndrome; Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia
Intervention: Drug: Human Placental Derived Stem Cell
Sponsors: New York Medical College; New York Medical College
Not yet recruiting - verified April 2012 - Condition: Alzheimer's Dementia
Intervention: Drug: ENA713
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Conditions: Agitation; Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine); Drug: Placebo
Sponsors: Avanir Pharmaceuticals; Avanir Pharmaceuticals
Not yet recruiting - verified April 2012 - Conditions: Dementia; Alzheimer Disease
Intervention: Other: Neuroimaging
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Not yet recruiting - verified April 2012 - Condition: Post-Stroke Cognitive Impairment (PSCI)
Interventions: Drug: Actovegin; Drug: Placebo
Sponsors: Nycomed; Nycomed
Not yet recruiting - verified April 2012 - Condition: Huntington Disease
Interventions: Drug: PBT2; Drug: PBT2; Drug: Placebo
Sponsors: Prana Biotechnology Limited; Prana Biotechnology Limited
Recruiting - verified May 2012 - Condition: Cognitive Symptoms
Intervention:
Sponsors: Washington University School of Medicine; Jay F. Piccirillo, MD; Washington University Siteman Cancer Center; Barnes-Jewish Hospital Foundation
Recruiting - verified April 2012 - Condition: Huntington's Disease
Intervention:
Sponsors: CHDI Foundation, Inc.; CHDI Foundation, Inc.
Not yet recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified April 2012 - Condition: Mild Cognitive Impairment
Interventions: Dietary Supplement: Grape Powder; Dietary Supplement: Placebo Powder
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified April 2012 - Condition: Cognitive Impairment
Interventions: Other: Dual task gait training; Other: Dual task gait training; Other: Aerobic exercise class
Sponsors: Parkwood Hospital, London, Ontario; Parkwood Hospital, London, Ontario; University of Western Ontario, Canada; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Pamlab, L.L.C.; Pamlab, L.L.C.; Clionsky Neuro Systems, Inc.
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Intervention:
Sponsors: CHU de Reims; CHU de Reims
Recruiting - verified April 2012 - Conditions: Post-operative Cognitive Decline; Post-operative Delirium
Interventions: Drug: Aspart insulin; Drug: Placebo
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Octohydroaminoacridine Succinate Tablets; Drug: Octohydroaminoacridine Succinate Tablets; Drug: Octohydroaminoacridine succinate Tablets; Drug: Placebo
Sponsors: Changchun Huayang High-tech Co., Ltd; Changchun Huayang High-tech Co., Ltd; Beijing Bionovo Medicine Development Co., Ltd.
Recruiting - verified May 2011 - Condition: Cognitive Impairment
Interventions: Behavioral: Active social engagement group; Behavioral: Control group
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Institute on Aging (NIA)
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Intervention: Other: Assessment of drive abilities
Sponsors: CHU de Reims; CHU de Reims
Not yet recruiting - verified March 2012 - Condition: Alzheimer Disease
Intervention: Other: CR1 impact
Sponsors: CHU de Reims; CHU de Reims
Recruiting - verified March 2012 - Condition: Dementia
Intervention: Behavioral: Goals of care decision support
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012 - Condition: Depressive Disorder, Major
Interventions: Drug: LuAA21004; Drug: Duloxetine; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Conditions: Huntington Disease; Huntington's Disease
Intervention:
Sponsors: European Huntington's Disease Network; European Huntington's Disease Network
Recruiting - verified May 2012 - Condition: Huntington Disease, Juvenile
Intervention:
Sponsors: European Huntington's Disease Network; European Huntington's Disease Network
Recruiting - verified May 2012 - Conditions: Cirrhosis; Hepatic Encephalopathy; Hyponatremia
Intervention: Drug: Tolvaptan
Sponsors: Hunter Holmes Mcguire Veteran Affairs Medical Center; Hunter Holmes Mcguire Veteran Affairs Medical Center; Otsuka America Pharmaceutical
Recruiting - verified March 2012 - Condition: Mentally Ill Old Subjects
Intervention:
Sponsors: University Hospital, Limoges; University Hospital, Limoges
Not yet recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: LY2886721; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Device: Deep Brain Stimulation
Sponsors: Ohio State University; Ali Rezai
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Biological: Albumin; Biological: Immune globulin
Sponsors: Grifols Biologicals Inc.; Instituto Grifols, S.A.; Grifols Biologicals Inc.
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Isotretinoin
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Other: Ophthalmological examination & Questionnaire
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Not yet recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Behavioral: assessment of memory; Biological: circulating tPA dosage; Genetic: ApoE4; Other: Brain imaging examination MRI and PET examinations
Sponsors: University Hospital, Caen; University Hospital, Caen; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified March 2012 - Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Not yet recruiting - verified March 2012 - Condition: Huntington Disease
Intervention:
Sponsors: Seoul National University Hospital; Seoul National University Hospital; European Huntington's Disease Network
Recruiting - verified March 2012 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Interventions: Other: Physical Training and cognitive activity (EPC group); Other: Physical training (EP group); Other: control group
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified January 2012 - Conditions: Mild Cognitive Impairment; Cognitive Disorders
Intervention: Behavioral: 5-month aerobic exercise intervention
Sponsors: Wake Forest University; Wake Forest University
Recruiting - verified March 2012 - Conditions: Effects of Chemotherapy; Cognitive Impairment
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: ABT-126; Drug: ABT-126; Drug: placebo
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Hypoxic Ischaemic Encephalopathy
Interventions: Drug: xenon gas; Device: Full body cooling
Sponsors: United Bristol Healthcare NHS Trust; United Bristol Healthcare NHS Trust; University of Bristol
Recruiting - verified May 2012 - Condition: HIV-Associated Cognitive Motor Complex
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Conditions: Mild Cognitive Impairment; Mild Alzheimer's Disease
Interventions: Drug: AZD5213; Drug: AZD5213; Drug: AZD5213; Other: Placebo
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified March 2012 - Condition: Dementia
Interventions: Behavioral: ESML-EX (Physical Activity Program); Behavioral: ESML-Social (Social Activity Program); Behavioral: Usual Care Control
Sponsors: University of Washington; University of Washington
Recruiting - verified March 2012 - Condition: Pain, Postoperative
Intervention:
Sponsors: Mahidol University; Mahidol University
Not yet recruiting - verified March 2012 - Condition: Hip Fracture
Interventions: Procedure: Femoral Nerve Catheterization; Procedure: Intravenous Opioids
Sponsors: Ochsner Health System; Leslie Thomas; American Society of Anesthesiologists
Recruiting - verified March 2012 - Conditions: Delirium; Advanced Cancer
Interventions: Drug: Olanzapine; Drug: Haloperidol
Sponsors: VU University Medical Center; VU University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified February 2012 - Condition: Caregivers of Persons With Dementia
Interventions: Behavioral: Sleep Behavioral Therapy A and NHMS; Behavioral: Sleep Behavioral Therapy B and NHMS
Sponsors: University of South Florida; University of South Florida; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012 - Conditions: Dementia; Alzheimer's Disease
Intervention: Other: PC-DATA tool
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: TTP4000; Drug: Placebo
Sponsors: TransTech Pharma; TransTech Pharma
Recruiting - verified March 2012 - Condition: Delirium
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified April 2012 - Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020; Drug: E2020
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified March 2012 - Conditions: Lewy Body Disease; Alzheimer's Disease
Intervention: Other: oculomotor measurements
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified January 2012 - Conditions: Alzheimer's Disease; Seizures
Intervention: Drug: Low/High/Placebo Dose Keppra (Levetiracetam)
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: MK-8931
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)Conditions: Cognition Disorders; Fatigue; Sleep Disorders; Other Complications of Bone Marrow Transplant
Interventions: Other: quality-of-life assessment; Other: questionnaire administration; Behavioral: management of therapy complications; Behavioral: cognitive assessment; Behavioral: educational intervention
Sponsors: Stanford University; Stanford University
Recruiting - verified March 2012 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Translational Research Informatics Center, Kobe, Hyogo, Japan; Translational Research Informatics Center, Kobe, Hyogo, Japan; Fudan University
Recruiting - verified March 2012 - Condition: Mild Cognitive Impairment
Intervention: Behavioral: Cognitive training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Nova Scotia Health Research Foundation
Not yet recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment
Interventions: Drug: Placebo Comparator; Drug: insulin detemir; Drug: insulin detemir
Sponsors: University of Washington; University of Washington; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
Sponsors: Novartis; Novartis Pharmaceuticals; Ono Pharma
Not yet recruiting - verified March 2012 - Condition: Postoperative Cognitive Dysfunction
Intervention:
Sponsors: University of Sao Paulo; Maria José Carvalho Carmona; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified March 2012 - Condition: Huntington's Disease
Interventions: Drug: SEN0014196; Drug: SEN0014196; Drug: Placebo
Sponsors: Siena Biotech S.p.A.; Siena Biotech S.p.A.
Recruiting - verified January 2012 - Condition: Mild Cognitive Impairment
Interventions: Drug: Atomoxetine; Drug: Placebo
Sponsors: Emory University; Emory University; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012 - Condition: Amnestic Mild Cognitive Impairment
Intervention: Behavioral: cognitive intervention
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Recruiting - verified February 2012 - Conditions: Delirium; Alteration of Cognitive Function; Incompetence, Functional
Interventions: Behavioral: Early and Intensive Occupational Therapy; Behavioral: Standard non-pharmacological delirium prevention
Sponsors: University of Chile; University of Chile; Fondo Nacional de Desarrollo Científico y Tecnológico, Chile; Fondo Nacional de Investigacion en Salud (FONIS); Escuela de Terapia Ocupacional, Facultad de Medicina
Recruiting - verified March 2012 - Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution; Biological: Human albumin 0.25%
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified May 2012 - Condition: Mild Cognitive Decline
Interventions: Dietary Supplement: Freeze-dried blueberries; Dietary Supplement: Dextrose Placebo
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Not yet recruiting - verified January 2012 - Conditions: Moderate to Severe Alzheimer; Alzheimer Disease
Interventions: Drug: RPh201, botanical drug product; Drug: Placebo; Drug: RPh201, botanical extract product; Drug: Placebo
Sponsors: Regenera Pharma Ltd; Regenera Pharma Ltd; Kendle Toronto, Inc, a wholly-owned subsidiary of INC Research LLC
Recruiting - verified January 2012 - Condition: Delirium Superimposed on Dementia
Intervention: Behavioral: END-DSD
Sponsors: Penn State University; Penn State University; Vanderbilt University; Harvard University; Georgia Health Sciences University
Recruiting - verified January 2012 - Conditions: Postoperative Pain; Delirium; Confusion; Sleep
Interventions: Drug: Melatonin; Drug: Placebo
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York
Recruiting - verified March 2012 - Conditions: Dementia; Cognitive Impairment
Intervention:
Sponsors: University Hospital of North Norway; University Hospital of North Norway; Kløveråsen Center for dementia, Bodø
Recruiting - verified May 2012 - Condition: Strabismus
Interventions: Drug: Dexmedetomidine; Drug: placebo group
Sponsors: Yonsei University; Yonsei University
Recruiting - verified January 2012 - Condition: Alzheimer Disease
Interventions: Behavioral: Aerobic Exercise; Behavioral: Control Group
Sponsors: Federal University of Rio de Janeiro; Federal University of Rio de Janeiro; Rio de Janeiro State Research Supporting Foundation (FAPERJ); Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified January 2012 - Conditions: Parkinson's Disease; Mild Cognitive Impairment
Interventions: Drug: Exelon Patch (rivastigmine transdermal system); Drug: Placebo Patches
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified January 2012 - Condition: Cognitive Impairment
Intervention: Other: Medication review
Sponsors: Umeå University; Umeå University
Recruiting - verified January 2012 - Condition: Delirium
Interventions: Drug: Haloperidol; Drug: Placebo
Sponsors: VU University Medical Center; VU University Medical Center
Not yet recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol; Drug: Placebo
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Cognitive Impairment, no Dementia (CIND)
Interventions: Behavioral: Aerobic Exercise; Behavioral: DASH diet; Other: Health education control
Sponsors: Duke University; Duke University
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2011 - Condition: Delirium
Interventions: Drug: Rivastigmine transdermal patch; Drug: placebo patch
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Novartis Pharmaceuticals
Recruiting - verified November 2011 - Conditions: Hepatic Encephalopathy; Liver Cirrhosis
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified September 2009 - Condition: Hunter Syndrome
Intervention: Drug: Idursulfase-IT
Sponsors: Shire Human Genetic Therapies, Inc.; Shire Human Genetic Therapies, Inc.
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027; Drug: BMS-241027; Drug: BMS-241027; Drug: Placebo matching BMS-241027
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MK-8931; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Alzheimer Disease; Battery
Interventions: Drug: Donepezil .; Drug: Placebo
Sponsors: University Hospital, Lille; University Hospital, Lille
Recruiting - verified October 2011 - Condition: Huntington's Disease
Intervention: Drug: SEN0014196
Sponsors: Siena Biotech S.p.A.; Siena Biotech S.p.A.
Recruiting - verified March 2012 - Conditions: SUSAC's Syndrome; Encephalopathy; Hearing Loss; Retinal Artery Branch Occlusions
Intervention: Device: Diffusion tensor magnetic resonance imaging of the brain
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified December 2010 - Conditions: Obstructive Sleep Apnea; Mild Cognitive Impairment
Intervention: Device: Continuous Positive Airway Pressure [CPAP]
Sponsors: George Mason University; George Mason University; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Condition: Hypoxic Ischemic Encephalopathy
Intervention:
Sponsors: University Children's Hospital, Zurich; University Children's Hospital, Zurich
Recruiting - verified December 2011 - Conditions: Aging; Memory Impairment; Cognitive Decline; Mild Cognitive Disorder
Intervention: Behavioral: Categorization training
Sponsors: University of Cyprus; University of Cyprus
Recruiting - verified November 2011 - Conditions: Alzheimer's Disease; Cognition Disorders
Intervention: Procedure: repetitive Transcranial Magnetic Stimulation (rTMS)
Sponsors: Centre Hospitalier Universitaire de Besancon; Pr Pierre Vandel; Neurology department of CHU Besancon (Dr Rumbach L, Dr Berger E, Dr Galmiche J); Memory Center of Research and Resources (MCRR) of Besancon (Dr Magnin E); Rapid-fr network (Dr Galmiche J); Clinical Investigation Centre - Technological Innovation (CIC-IT808); Funding by French Internal Project Call for Clinical Research(2010-A00659-30)
Recruiting - verified November 2011 - Condition: Dementia
Interventions: Behavioral: The Talking Sense manual; Behavioral: Treatment as usual - communication information and advice
Sponsors: University of Portsmouth; University of Portsmouth; Solent NHS Primary Care Trust; The Sir Halley Stewart Trust
Recruiting - verified March 2012 - Conditions: Apathy; Alzheimer's Disease
Intervention: Procedure: Transcranial direct current stimulation
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified January 2012 - Conditions: Alzheimer's Disease; Multiple Sclerosis; Parkinson's Disease; Huntington's Disease
Intervention: Other: blood samples
Sponsors: Sanguine Biosciences; Sanguine Biosciences
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: SAR228810; Drug: SAR228810
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Mild Alzheimer's Disease; Mild Cognitive Impairment
Interventions: Drug: HPP854; Drug: Placebo
Sponsors: High Point Pharmaceuticals, LLC.; High Point Pharmaceuticals, LLC.
Recruiting - verified February 2012 - Conditions: Impaired Cognition; Schizophrenia
Interventions: Drug: Donepezil; Drug: placebo
Sponsors: Central South University; Central South University
Recruiting - verified December 2011 - Condition: Hypoxic Ischemic Encephalopathy
Interventions: Drug: Darbepoetin alfa; Drug: Darbepoetin alfa; Drug: Placebo
Sponsors: University of Utah; University of Utah
Not yet recruiting - verified May 2012 - Conditions: Surgery; Critical Illness; Mechanical Ventilation Complication; Organ Dysfunction Syndrome; Intensive Care Unit Syndrome
Intervention: Other: Therapy strategy
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Recruiting - verified December 2011 - Condition: Alzheimer's Disease
Intervention: Drug: Galantamine
Sponsors: Janssen Pharmaceutical K.K.; Janssen Pharmaceutical K.K.
Recruiting - verified May 2012 - Conditions: Vascular Dementia; Subcortical Vascular Dementia
Interventions: Drug: Zydena (Udenafil); Drug: Placebo
Sponsors: Samsung Medical Center; Samsung Medical Center; Dong-A Pharmaceutical Co., Ltd.
Not yet recruiting - verified November 2011 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: AZD3480
Sponsors: Targacept Inc.; Targacept Inc.
Recruiting - verified May 2012 - Conditions: Anxiety Disorder; Breast Cancer; Cancer Survivor; Cognitive/Functional Effects; Depression; Fatigue; Sleep Disorders
Interventions: Drug: donepezil hydrochloride; Other: placebo
Sponsors: National Cancer Institute (NCI); Wake Forest University; National Cancer Institute (NCI)
Not yet recruiting - verified November 2011 - Condition: Alzheimers Disease
Interventions: Drug: Liraglutide; Drug: non-active study drug
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment; Vascular Dementia; Fronto-temporal Dementia; Primary Progressive Aphasia; Parkinson' Disease Dementia; Mixed Dementia
Intervention:
Sponsors: Exonhit; Exonhit
Recruiting - verified December 2011 - Conditions: Cognitive Impairments; Schizotypal Personality Disorder
Interventions: Drug: DAR-0100A; Drug: Placebo
Sponsors: Mount Sinai School of Medicine; Larry J. Siever; New York State Psychiatric Institute
Recruiting - verified November 2011 - Conditions: Cognitive Impairment; Cardiac Disease; Heart Failure
Intervention:
Sponsors: Kent State University; Kent State University; Summa Health System; Case Western Reserve University; University Hospitals of Cleveland
Recruiting - verified October 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Interventions: Drug: Minocycline; Drug: Sugar Pill
Sponsors: Huntington Medical Research Institutes; Huntington Medical Research Institutes
Recruiting - verified January 2012 - Condition: Mild Cognitive Impairment
Interventions: Device: H-Coil Deep TMS; Device: SHAM Coil TMS
Sponsors: Brainsway; Brainsway
Not yet recruiting - verified November 2011 - Conditions: Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; PLS; Motor Neuron Disease; Lou Gehrigs Disease; Familial Disease; Amyotrophic Lateral Sclerosis, Sporadic
Intervention:
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified May 2012 - Conditions: Alcoholism; Alcohol Amnestic Disorder
Interventions: Behavioral: Neuropsychological testing; Biological: blood draw; Genetic: genetic testing; Other: Brain imaging examination
Sponsors: University Hospital, Caen; University Hospital, Caen; Institut National de la Santé Et de la Recherche Médicale, France; Agence Nationale de la Recherche
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Schizophrenia
Interventions: Drug: amisulpride; Drug: amisulpride; Drug: amisulpride
Sponsors: Institute of Psychiatry, London; Institute of Psychiatry, London
Not yet recruiting - verified October 2011 - Condition: Alzheimer's Disease
Interventions: Other: PET scan using florbetapir; Other: MRI Scan
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Huntington's Disease
Intervention:
Sponsors: Ohio State University; Ohio State University; Lundbeck LLC
Recruiting - verified November 2011 - Conditions: Alzheimer Disease; Cognitive Impairment
Interventions: Drug: Sodium oligo-mannurarate 600mg; Drug: Sodium oligo-mannurarate 900mg; Drug: Placebo
Sponsors: Shanghai Greenvalley Pharmaceutical Co., Ltd.; Shanghai Greenvalley Pharmaceutical Co., Ltd.; Shanghai Mental Health Center
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS); Behavioral: NICE Cognitive Training
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; Neuronix Ltd
Recruiting - verified March 2012 - Condition: Mild Cognitive Impairment
Interventions: Other: Cognitive intervention; Other: Psychosocial intervention
Sponsors: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Laval University
Not yet recruiting - verified October 2011 - Conditions: Parkinson Disease; Alzheimer Disease
Intervention: Drug: [18F] CFPyPB
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified May 2012 - Conditions: Neurodegenerative Diseases; Memory Disturbances
Intervention:
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Center for Translational Molecular Medicine; Leiden University Medical Center; Radboud University; VU University Medical Center
Recruiting - verified October 2011 - Conditions: End Stage Liver Disease; Hepatic Encephalopathy
Intervention:
Sponsors: Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein
Not yet recruiting - verified September 2011 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Centre Hospitalier Esquirol; Centre Hospitalier Esquirol
Recruiting - verified February 2010 - Condition: Alzheimer's Disease
Intervention: Drug: Simvastatin + L-Arginine + Tetrahydrobiopterin
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Insulin glulisine; Drug: Placebo : Placebo Comparator
Sponsors: HealthPartners Research Foundation; HealthPartners Research Foundation
Recruiting - verified November 2011 - Conditions: Healthy; Alzheimer Disease
Interventions: Procedure: Standard CSR sampling procedure; Procedure: Alternate frequency CSR sampling procedure; Procedure: Standard frequent CSR sampling procedure with 800 mg ibuprofen; Procedure: Standard CSR sampling procedure
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Conditions: Alzheimer Disease; Depression
Intervention: Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam
Sponsors: Centre Hospitalier Universitaire de Besancon; Pr Pierre Vandel; Psychology laboratory of Besançon EA 3188; Centre Hospitalier Universitaire Dijon; Hospital of Novillars; funding by French Hospital Progeram of Clinical Research (PHRC 2009-A00942-55)
Recruiting - verified September 2011 - Condition: HIV-1-Associated Cognitive Motor Complex
Intervention:
Sponsors: Holdsworth House Medical Practice; Holdsworth House Medical Practice
Recruiting - verified November 2011 - Condition: Alzheimer Disease
Intervention: Other: Hypnotherapy
Sponsors: Families To The Rescue; Families To The Rescue
Available - verified October 2011 - Condition: Mild Cognitive Impairment
Interventions: Behavioral: APOE genotype disclosure and Alzheimer's disease risk disclosure; Behavioral: Alzheimer's disease risk disclosure
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Human Genome Research Institute (NHGRI); University of Michigan; University of Pennsylvania; Howard University
Recruiting - verified September 2011 - Condition: Dementia
Intervention:
Sponsors: Laval University; Laval University
Not yet recruiting - verified September 2011 - Conditions: Mild Cognitive Impairment; Alzheimers Disease
Intervention:
Sponsors: Oslo University Hospital; Oslo University Hospital; South Eastern Area Health Service
Not yet recruiting - verified November 2011 - Conditions: Mild Cognitive Impairment; Dementia
Interventions: Drug: ladostigil hemitartrate; Drug: Placebo
Sponsors: Avraham Pharmaceuticals Ltd; Avraham Pharmaceuticals Ltd
Recruiting - verified March 2012 - Conditions: Liver Failure; Liver Transplantation; Encephalopathy
Interventions: Other: Near infrared spectroscopy monitoring; Other: Autoregulation monitoring
Sponsors: Johns Hopkins University; Johns Hopkins University
Not yet recruiting - verified August 2011 - Condition: Alzheimer's Disease
Interventions: Drug: rilapladib; Drug: placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: VI-1121; Drug: Placebo
Sponsors: VIVUS, Inc.; VIVUS, Inc.; Medpace, Inc.
Recruiting - verified April 2012 - Condition: MILD COGNITIVE IMPAIRMENT
Intervention: Procedure: Lumbar puncture
Sponsors: Qualissima; Qualissima; European Union
Recruiting - verified December 2011 - Conditions: Alzheimer's Disease; Cardiovascular Risk Factors
Intervention: Other: optimal care of VRF
Sponsors: University Hospital, Lille; Florence PASQUIER; Assistance Publique - Hôpitaux de Paris; University Hospital, Rouen; Amiens University Hospital; University Hospital, Bordeaux; Centre Hospitalier Boulogne; Centre Hospitalier VALENCIENNES; Centre Hospitalier Lens; Centre Hospitalier Béthune; Centre Hospitalier Roubaix; Centre Hospitalier Saint-Philibert, GHICL; Hôpital des Bâteliers, Lille; Centre Hospitalier Calais; Centre Hospitalier Saint-Omer
Recruiting - verified October 2009 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 20 mg
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Conditions: Personality Disorder; Depression; Neurodegeneration; Alzheimer's Disease; Epilepsy
Intervention: Device: EEG recording
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Not yet recruiting - verified August 2011 - Condition: Alzheimer Disease
Interventions: Behavioral: Web-based psycho-educational program; Behavioral: Consultation in memory clinic
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Direction de l’Hospitalisation et de l’Organisation des Soins (PREQHOS); Fondation Médéric Alzheimer
Not yet recruiting - verified August 2011 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Gulhane Military Medical Academy; Gulhane Military Medical Academy
Recruiting - verified August 2011 - Conditions: ICU Delirium; Immobility
Intervention:
Sponsors: University of Nebraska; University of Nebraska; Robert Wood Johnson Foundation
Recruiting - verified April 2012 - Condition: Alzheimer's Dementia
Interventions: Drug: Cilostazol; Drug: Placebo
Sponsors: Seoul National University Hospital; Seoul National University Hospital; Korea OIAA
Recruiting - verified August 2011 - Conditions: Down Syndrome; Amyloid Deposition; Alzheimers Disease
Intervention:
Sponsors: University of Pittsburgh; University of Pittsburgh; University of Wisconsin, Madison
Recruiting - verified August 2011 - Condition: Alzheimer Disease
Interventions: Drug: Memantine; Drug: Vitamin D; Drug: Vitamin D placebo
Sponsors: University Hospital, Angers; University Hospital, Angers
Recruiting - verified March 2011 - Condition: Alzheimer's Disease
Intervention: Drug: Sagramostim
Sponsors: University of South Florida; University of South Florida; The Dana Foundation
Recruiting - verified August 2011 - Conditions: Substance Abuse; Substance Dependence; Cognitive Impairment
Interventions: Behavioral: Cognitive Training + Work Therapy; Behavioral: Work Therapy
Sponsors: Yale University; Yale University
Recruiting - verified August 2011 - Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020; Drug: Placebo
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment; Age-Related Memory Disorders
Intervention:
Sponsors: University of Arizona; University of Arizona; Banner Sun Health Research Institute; Barrow Neurological Institute; Mayo Clinic; National Institute on Aging (NIA); National Institutes of Health (NIH)
Recruiting - verified August 2011 - Conditions: Early Onset Alzheimer Disease; Alzheimer Disease; Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment; Device: No treatment
Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Centre Hospitalier Universitaire de Saint Etienne; Association Lyonnaise de Logistique Posthospitalière
Recruiting - verified February 2012 - Conditions: Alzheimer Disease; Mild Cognitive Impairment; Neurodegenerative Diseases
Intervention: Drug: Florbetapir F 18
Sponsors: Avid Radiopharmaceuticals; Avid Radiopharmaceuticals
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine; Drug: Rivastigmine
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified August 2011 - Condition: Dementia
Intervention: Other: Provision of a "Dementia Care Manager"
Sponsors: German Center for Neurodegenerative Diseases (DZNE); German Center for Neurodegenerative Diseases (DZNE); University Medicine Greifswald
Not yet recruiting - verified August 2011 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified July 2011 - Condition: Dementia in Nursing Home
Intervention: Other: MultiDisciplinary Team Meetings (MDTM)
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse
Recruiting - verified March 2012 - Conditions: Delirium; Cardiac Disease
Interventions: Drug: Propofol; Drug: Dexmedetomidine
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Hospira, Inc.
Recruiting - verified June 2011 - Conditions: Stroke; Cognitive Impairment
Interventions: Drug: Galantamine; Drug: placebo
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BIIB037; Other: Placebo
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified July 2011 - Condition: Alzheimer's Disease
Intervention: Drug: R-pramipexole
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; University of Kansas; Alzheimer’s Drug Discovery Foundation
Recruiting - verified January 2012 - Condition: Frontotemporal Dementia
Interventions: Drug: oxytocin; Drug: Saline Nasal Mist
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)
Recruiting - verified June 2011 - Condition: Dementia
Interventions: Drug: roflumilast (EU: Daxas, USA: Daliresp); Drug: Placebo; Drug: roflumilast
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified November 2011 - Conditions: Aortic Valve Replacement; Aortic Stenosis
Intervention: Other: Thoracic paravertebral block (PVB)
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified July 2011 - Conditions: Dementia; Pain
Intervention: Behavioral: Preventing Aggression in Veterans with Dementia (PAVeD)
Sponsors: Michael Debakey Veterans Affairs Medical Center; Michael Debakey Veterans Affairs Medical Center; South Central VA Mental Illness Research, Education & Clinical Center
Not yet recruiting - verified June 2011 - Condition: Huntington Disease
Interventions: Other: Huntington patient evaluation; Other: Healthy subject evaluation
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2011 - Conditions: Cognitive Impairment; Stroke
Intervention: Behavioral: Telerehabilitation Cognitive Strategy Training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; IWK Health Centre; Canadian Institutes of Health Research (CIHR)
Recruiting - verified August 2011 - Conditions: Age-associated Cognitive Impairment; Mild Cognitive Impairment (MCI)
Interventions: Dietary Supplement: Curcumin; Dietary Supplement: Sugar pill
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention: Drug: rivastigmine patch
Sponsors: Dong-A University; Dong-A University; Novartis Korea Ltd.
Not yet recruiting - verified April 2011 - Conditions: Amyotrophic Lateral Sclerosis; Alzheimer Disease; Parkinson's Disease
Intervention:
Sponsors: China Medical University Hospital; China Medical University Hospital
Not yet recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: MSDC-0160; Drug: Placebo
Sponsors: Metabolic Solutions Development Company; Metabolic Solutions Development Company
Recruiting - verified November 2011 - Conditions: Mild Cognitive Disorder; Mild Cognitive Impairment
Interventions: Drug: Exelon [rivastigmine] transdermal patch; Drug: Placebo patch
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified May 2012 - Condition: Progressive Cognitive Decline
Intervention: Drug: florbetapir F 18
Sponsors: Avid Radiopharmaceuticals; Avid Radiopharmaceuticals
Recruiting - verified May 2012 - Conditions: HIV; Impaired Cognition
Interventions: Drug: standard care; Drug: novel treatment
Sponsors: Imperial College London; Imperial College London; Pfizer
Not yet recruiting - verified June 2011 - Conditions: Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Multiple Sclerosis (MS); Parkinson's Disease; Stroke; Traumatic Brain Injury
Intervention:
Sponsors: Avanir Pharmaceuticals; Avanir Pharmaceuticals
Recruiting - verified May 2011 - Conditions: Cognitive Impairment; Stroke
Intervention: Drug: choine alphoscerate (alpha-glyceryl phosphoryl choline)
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified May 2011 - Condition: Alzheimer Disease
Intervention: Other: observational
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified May 2011 - Conditions: Dementia; Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Galantamine; Drug: Rivastigmine
Sponsors: Regenstrief Institute, IU Center for Aging Research; Regenstrief Institute, IU Center for Aging Research; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified June 2011 - Condition: Huntington Disease
Interventions: Other: 31P-MR spectroscopy; Other: 31P-RMN spectroscopy
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified January 2012 - Condition: Huntington's Disease (HD)
Interventions: Drug: (2)-epigallocatechin-3-gallate (EGCG); Drug: Placebo
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified November 2011 - Condition: Dementia
Intervention: Other: Tailored Activity Program
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Condition: CADASIL
Interventions: Drug: Dabigatran; Drug: Antiplatelets
Sponsors: S. Andrea Hospital; S. Andrea Hospital
Recruiting - verified May 2011 - Condition: Alzheimer's Disease
Interventions: Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812)
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Carvedilol; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; Mount Sinai School of Medicine
Recruiting - verified March 2012 - Conditions: Depression; Dementia; Geriatrics
Interventions: Behavioral: Problem Adaptation Therapy (PATH); Behavioral: Supportive Therapy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Conditions: HIV Infections; Central Nervous System Diseases; Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine; Drug: tenofovir-lamivudine-efavirenz
Sponsors: University of California, San Diego; University of California, San Diego; National Institute of Mental Health (NIMH); National Center for AIDS/STD Control and Prevention, China CDC; Beijing YouAn Hospital; Beijing Ditan Hospital
Recruiting - verified January 2012 - Conditions: Neurocognitive Disturbance; HIV Infection
Interventions: Drug: Lithium; Drug: Rivastigmine; Behavioral: not initiate treatment
Sponsors: Fundacio Lluita Contra la SIDA; Fundacio Lluita Contra la SIDA
Recruiting - verified April 2012 - Conditions: Ischemic Stroke; Hemorrhagic Stroke
Intervention:
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Recruiting - verified December 2011 - Condition: Dementia With Lewy Bodies
Intervention: Procedure: Electrical stimulation of the nucleus basalis of Meynert
Sponsors: University Hospital, Rouen; University Hospital, Rouen
Not yet recruiting - verified April 2012 - Conditions: Alzheimer Disease; Stroke; Parkinson's Disease; Lewy Body Dementia; Huntington Disease
Intervention: Behavioral: Computerized tests and Electrophysiological measurements
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified April 2011 - Conditions: Dementia; Aggression; Pain
Interventions: Behavioral: PAVeD Intervention; Behavioral: Enhanced Usual Care
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Condition: Postoperative Delirium
Intervention: Behavioral: Multifaceted prevention program HELP(Hospital Elder Life Program)
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified July 2011 - Condition: Alzheimer's Disease
Interventions: Drug: ORM-12741; Drug: ORM-12741; Drug: Placebo for ORM-12741
Sponsors: Orion Corporation, Orion Pharma; Orion Corporation, Orion Pharma
Recruiting - verified February 2012 - Conditions: Symptomatic Menopause; Cognitive Impairments
Intervention: Drug: Lisdexamfetamine
Sponsors: University of Pennsylvania; University of Pennsylvania; Shire Development LLC
Recruiting - verified April 2012 - Condition: Maximum Diagnostic Mass of [18Fluor]AZD4694
Interventions: Other: [18Fluor]AZD4694; Other: [18Fluor]AZD4694; Other: [18Fluor]AZD4694
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified August 2011 - Conditions: Alzheimer's Disease; Impaired Cognition; Memory Disorders
Intervention:
Sponsors: University Hospital, Angers; University Hospital, Angers
Recruiting - verified March 2011 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified December 2011 - Condition: Alzheimer's Disease
Interventions: Behavioral: Home based occupational therapy; Behavioral: Best practices primary care
Sponsors: Regenstrief Institute, IU Center for Aging Research; Regenstrief Institute, IU Center for Aging Research; National Institute on Aging (NIA)
Recruiting - verified August 2011 - Condition: Alzheimer's Disease
Interventions: Behavioral: Healthy Lifestyle Program; Behavioral: Physical Activity Intervention
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; Programs of All-Inclusive Care for the Elderly (PACE) of Baton Rouge
Recruiting - verified March 2011 - Condition: Drug Addiction
Intervention: Drug: Varenicline
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified December 2011 - Conditions: Niemann-Pick Disease; Niemann-Pick Disease, Type C
Intervention:
Sponsors: University of Rostock; University of Rostock
Recruiting - verified March 2011 - Condition: Dementia
Interventions: Behavioral: New York University Caregiver Intervention (NYUCI); Behavioral: Community-based case management using community health workers (CHWs).
Sponsors: Columbia University; Columbia University; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple SclerosisConditions: Multiple Sclerosis; Cognitive Impairment
Interventions: Behavioral: Self-management cognitive rehabilitation group intervention; Behavioral: Control intervention
Sponsors: Tel Aviv University; Tel Aviv University
Recruiting - verified February 2012 - Conditions: Stroke; Cognitive Disorders; Behavioral Disorders
Intervention: Behavioral: French adaptation of NINDS-CSN battery
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified February 2011 - Condition: Postural Tachycardia Syndrome
Interventions: Behavioral: Seated Measurements; Behavioral: Standing Measurements; Behavioral: Self-Administered Surveys
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Intervention: Behavioral: questioning
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified December 2011 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Columbia University; Columbia University; National Institute on Aging (NIA)
Recruiting - verified August 2011 - Conditions: Dementia; Behavioral and Psychological Symptoms of Dementia
Interventions: Drug: Delta(9)-tetrahydrocannabinol (Delta-THC); Drug: Delta(9)-tetrahydrocannabinol; Drug: Placebo; Drug: Delta(9)-tetrahydrocannabinol (Delta-THC)
Sponsors: Radboud University; Radboud University
Recruiting - verified March 2012 - Condition: Breast Cancer
Intervention: Behavioral: Exercise
Sponsors: University of British Columbia; University of British Columbia; Canadian Breast Cancer Foundation
Recruiting - verified February 2012 - Condition: Delirium, Postoperative
Interventions: Drug: Placebo; Drug: Dexmedetomidine
Sponsors: Huazhong University of Science and Technology; Huazhong University of Science and Technology
Recruiting - verified September 2011 - Condition: Huntington's Disease
Intervention:
Sponsors: CHDI Foundation, Inc.; CHDI Foundation, Inc.; Monash University
Recruiting - verified February 2012 - Conditions: Delirium; Sleep Disorders, Circadian Rhythm
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; Masimo Labs
Recruiting - verified March 2012 - Conditions: Delirium; Confusion
Interventions: Other: Dynamic Light; Other: Normal Light
Sponsors: Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis
Recruiting - verified December 2011 - Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: E2020; Drug: E2020; Drug: Placebo
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified October 2011 - Condition: Mild Cognitive Impairment
Interventions: Behavioral: Memory Support System; Behavioral: Computer Training
Sponsors: Emory University; Emory University; Mayo Clinic; National Institute of Nursing Research (NINR)
Recruiting - verified June 2011 - Conditions: Delirium; Dementia
Intervention: Behavioral: Cognitive Stimulation
Sponsors: Penn State University; Penn State University
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Interventions: Behavioral: Comprehensive, CBT-based, multi-component treatment; Behavioral: Treatment as usual
Sponsors: University of Zurich; University of Zurich; Psychiatric University Hospital, Zurich
Recruiting - verified October 2011 - Conditions: Memory Loss; Cognitive Changes; Postmenopausal Symptoms
Intervention: Drug: Estradiol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute on Aging (NIA)
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Intervention: Drug: [18F]-FMH3
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Cognitive Impairment; Schizophrenia
Interventions: Drug: Eltoprazine; Drug: Placebo
Sponsors: PsychoGenics Inc.; PsychoGenics Inc.
Recruiting - verified May 2012 - Condition: HIV Dementia
Intervention: Drug: Atorvastatin
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Exendin-4 (Exenatide)
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Aging (NIA)
Recruiting - verified February 2010 - Condition: Alzheimer Disease
Interventions: Drug: Donepezil,; Drug: STA-1; Drug: placebo
Sponsors: Sinphar Pharmaceutical Co., Ltd; Sinphar Pharmaceutical Co., Ltd
Not yet recruiting - verified July 2011 - Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention: Drug: SK-PC-B70M
Sponsors: SK Chemicals Co.,Ltd.; SK Chemicals Co.,Ltd.
Recruiting - verified November 2010 - Condition: Hypoxic Ischemic Encephalopathy
Intervention: Drug: Topiramate in newborns with hypoxic ischemic encephalopathy treated with therapeutic hypothermia
Sponsors: Azienda Ospedaliero, Universitaria Meyer; Azienda Ospedaliero, Universitaria Meyer; Azienda Ospedaliero, Universitaria Pisana
Recruiting - verified January 2012 - Conditions: Brain Injuries; Dementia; Myopathies; Muscle Disorders
Interventions: Behavioral: Behavioral: Physical and functional rehabilitation; Behavioral: Behavioral: Cognitive, physical, & functional rehabilitation
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified January 2012 - Conditions: Oxidative Stress; Inflammation; Aging; Dementia; Pain
Intervention: Dietary Supplement: secoisolariciresinol diglucoside
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified October 2011 - Condition: Alzheimer Disease
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Conditions: Mild Cognitive Impairment (MCI); Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A; Drug: Placebo Comparator B; Drug: Active Comparator B; Drug: Placebo Comparator A
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Biological: ACC-001; Biological: ACC-001; Biological: ACC-001
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Late Onset Alzheimer Disease
Intervention: Drug: BAY 94-9172 (Florbetaben)
Sponsors: New York State Psychiatric Institute; Yaakov Stern; Bayer; National Institute on Aging (NIA)
Recruiting - verified January 2012 - Condition: Alzheimer Disease
Interventions: Drug: gantenerumab; Drug: gantenerumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: E2212; Drug: placebo
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified June 2011 - Condition: Mild Cognitive Impairment
Interventions: Behavioral: caloric restriction; Behavioral: omega-3 supplementation; Behavioral: resveratrol supplementation; Behavioral: Placebo; Behavioral: 2nd step: intervention + physical / cognitive training; Behavioral: 2nd step: intervention + control
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; German Federal Ministry of Education and Research
Recruiting - verified August 2010 - Conditions: Delirium; Impaired Cognition; Long Term Psychologic Disorders
Interventions: Drug: Haloperidol; Drug: Ziprasidone; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified December 2011 - Conditions: Cerebrovascular Disorders; Dementia
Intervention:
Sponsors: University Hospital, Lille; University Hospital, Lille; Ministry of Health, France
Recruiting - verified July 2010 - Condition: Mild Cognitive Impairment (MCI)
Intervention: Behavioral: mentally stimulating activities
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA)
Recruiting - verified June 2011 - Conditions: Brain Mapping; Intracranial Central Nervous System Disorder; Epilepsy; Auditory Perceptual Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Deafness and Other Communication Disorders (NIDCD); National Institute of Deafness and Other Communication Disorders
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: caprylic triglyceride; Drug: long-chain triglyceride
Sponsors: Accera, Inc.; Accera, Inc.
Not yet recruiting - verified June 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease; Dementia With Lewy Bodies; Vascular Dementia
Intervention:
Sponsors: Skåne University Hospital; Skåne University Hospital; Lund University
Recruiting - verified September 2010 - Condition: Delirium
Interventions: Drug: Xenon; Drug: Sevoflurane
Sponsors: Air Liquide Santé International; Air Liquide Santé International; i3 Innovus
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Intervention: Drug: Drug: [18F] PBR111
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Intervention: Other: 18F-PIB
Sponsors: University of Utah; University of Utah
Recruiting - verified September 2011 - Conditions: Infant, Newborn; Hypoxia, Brain; Hypoxia-Ischemia, Brain; Encephalopathy, Hypoxic-Ischemic; Hypoxic-Ischemic Encephalopathy; Ischemic-Hypoxic Encephalopathy
Intervention: Procedure: Whole-body Cooling
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR)
Recruiting - verified February 2012 - Condition: Alzheimer's Dementia
Intervention: Device: Resonator
Sponsors: pico-tesla Magnetic Therapies, LLC; pico-tesla Magnetic Therapies, LLC
Recruiting - verified June 2011 - Conditions: Alzheimer's Disease; Capacity to Consent to Treatment; Capacity to Vote; Capacity to Design a Proxy
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2010 - Condition: Alzheimer's Disease
Interventions: Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Other: Placebo
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified May 2012 - Condition: Subsyndromal Delirium
Interventions: Drug: Haloperidol decanoate; Drug: Placebo
Sponsors: Northeastern University; Northeastern University; National Institute on Aging (NIA)
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention: Device: TMS, H coil
Sponsors: Brainsway; Brainsway
Recruiting - verified July 2011 - Conditions: Cognitive Deterioration; Disorder of Aging
Interventions: Behavioral: aerobic training; Behavioral: Wait list
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified March 2012 - Condition: Delirium
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified August 2011 - Condition: Delirium
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified August 2011 - Conditions: Liver Cirrhosis; Hepatic Encephalopathy
Intervention:
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified June 2011 - Condition: Delirium
Interventions: Drug: Dexmedetomidine; Drug: Saline placebo
Sponsors: Austin Health; Austin Health; Hospira Pty Ltd
Recruiting - verified May 2010 - Condition: Major Depressive Disorder
Intervention: Drug: Lisdexamfetamine Dimesylate 20-50 mg
Sponsors: Mclean Hospital; Mclean Hospital; Shire Development LLC
Recruiting - verified March 2012 - Condition: Delirium
Interventions: Drug: Clonidine; Drug: Placebo
Sponsors: Memorial Health University Medical Center; Memorial Health University Medical Center
Recruiting - verified August 2011 - Conditions: Frontotemporal Dementia; Frontotemporal Degeneration; Alzheimer's Disease; Social Behavior
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Aging (NIA)
Recruiting - verified October 2011 - Condition: Alzheimer's Disease
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Washington; University of Washington; Seattle Institute for Biomedical and Clinical Research; VA Puget Sound Health Care System
Recruiting - verified March 2012 - Conditions: Alcohol Withdrawal Delirium; Alcohol Withdrawal Associated Autonomic Hyperactivity; Alcohol Withdrawal Hallucinosis; Alcohol Withdrawal-Induced Delirium Tremens
Interventions: Drug: Dexmedetomidine; Drug: Placebo
Sponsors: Denver Health and Hospital Authority; Denver Health and Hospital Authority
Recruiting - verified April 2012 - Condition: Hypertension
Intervention:
Sponsors: Columbia University; Columbia University; Mount Sinai School of Medicine; Weill Medical College of Cornell University
Recruiting - verified February 2012 - Conditions: Hepatic Cirrhosis; Minimal Hepatic Encephalopathy
Interventions: Other: Auxiliary Treatment; Dietary Supplement: Hyperproteic and fiber-rich diet; Drug: Nitazoxanide
Sponsors: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Intervention: Other: Alzhamyd
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified May 2010 - Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Behavioral: Aerobic Exercise; Behavioral: Stretching
Sponsors: University of Kansas; University of Kansas
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: Prazosin; Drug: Placebo
Sponsors: Seattle Institute for Biomedical and Clinical Research; Seattle Institute for Biomedical and Clinical Research; National Institute on Aging (NIA); VA Puget Sound Health Care System
Recruiting - verified February 2012 - Condition: Alzheimer Disease
Interventions: Dietary Supplement: caprylidene; Dietary Supplement: Placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles; John Douglas French Foundation
Recruiting - verified October 2010 - Condition: Alzheimer's Disease
Interventions: Drug: Tamibarotene; Drug: Placebo
Sponsors: Osaka City University; Osaka City University
Recruiting - verified July 2011 - Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3; Other: Placebo
Sponsors: CD Pharma India Pvt. Ltd.; CD Pharma India Pvt. Ltd.; Postgraduate Institute of Medical Education and Research
Recruiting - verified June 2011 - Condition: Femoral Neck Fracture
Interventions: Drug: periarticular injection of multidrug regimen; Drug: none of medication preoperatively and intraoperatively
Sponsors: Chung-Ang Univerisity Hospital; Chung-Ang Univerisity Hospital
Recruiting - verified April 2010 - Condition: Alzheimer's Disease
Interventions: Biological: active: AFFITOPE AD02; Biological: control: Placebo
Sponsors: Affiris AG; Affiris AG
Recruiting - verified November 2011 - Conditions: Ischemic Stroke; Cognitive Decline; Dementia
Intervention: Behavioral: Motivation and lifestyle intervention
Sponsors: Danube University Krems; Danube University Krems; Life Science Krems GmbH
Recruiting - verified June 2010 - Conditions: Mild Cognitive Impairment; Lack of Physical Activity
Intervention: Behavioral: Virtual Action Planning Supermarket (VAP-S) Software
Sponsors: Carmel Medical Center; Carmel Medical Center
Recruiting - verified July 2011 - Condition: Alzheimer Disease
Interventions: Behavioral: Errorless Learning; Behavioral: Modeling; Behavioral: Trial and Error
Sponsors: Centre Hospitalier Universitaire de Nice; Department of Clinical Research and Innovation; Institut National de la Santé Et de la Recherche Médicale, France; Fondation Mederic Alzheimer
Recruiting - verified December 2011 - Conditions: Alzheimer's Disease; Posterior Cortical Atrophy; Logopenic Progressive Aphasia
Intervention:
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified February 2012 - Conditions: Alzheimer Disease or Associated Disorder; Mild to Moderately Severe Dementia
Intervention: Other: Intervention of the social worker
Sponsors: Institut de Sante Publique, d'Epidemiologie et de Developpement; Institut de Sante Publique, d'Epidemiologie et de Developpement
Recruiting - verified July 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Mild Dementia
Intervention:
Sponsors: University Hospital, Ghent; University Hospital, Ghent
Recruiting - verified November 2011 - Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Rifaximin; Drug: rifaximin
Sponsors: Hunter Holmes Mcguire Veteran Affairs Medical Center; Hunter Holmes Mcguire Veteran Affairs Medical Center; Salix Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Amnestic Mild Cognitive Impairment
Intervention: Drug: Posiphen® tartrate capsules
Sponsors: QR Pharma Inc.; QR Pharma Inc.
Recruiting - verified June 2011 - Conditions: Mild Cognitive Impairment (MCI); Mild Alzheimer's Disease
Interventions: Other: auditory discrimination training; Other: physical movement training
Sponsors: University of Konstanz; University of Konstanz; University of Ulm
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention: Drug: lipoic acid and fish oil concentrate
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified May 2012 - Condition: Post-Traumatic Headache
Interventions: Drug: sumatriptan/naproxen sodium; Drug: Placebo
Sponsors: Cady, Roger, M.D.; Cady, Roger, M.D.; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Apathy in Dementia
Interventions: Drug: Elontril; Drug: placebo
Sponsors: University Hospital, Bonn; University Hospital, Bonn; Center for Clinical Trials ZKS Cologne; Department of Psychiatry Charite Campus Benjamin Franklin Berlin; Department of Psychiatry Charite Campus Mitte Berlin; Universität Duisburg-Essen; Department of Psychiatry University of Erlangen; Center for Geriatric Psychiatry University of Freiburg; Department of Psychiatry University of Hamburg; University of Heidelberg; Central Institute for Mental Health Mannheim; Philipps University Marburg Medical Center; Ludwig-Maximilians - University of Munich
Recruiting - verified July 2010 - Condition: Mild Cognitive Impairment
Intervention: Drug: Ginkgo biloba
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified October 2011 - Condition: Mild Cognitive Impairment (MCI)
Interventions: Drug: Levetiracetam; Drug: Placebo; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate; Drug: Lactose
Sponsors: Centro Regional para el Estudio de las Enfermedades Digestivas; Centro Regional para el Estudio de las Enfermedades Digestivas
Recruiting - verified June 2011 - Conditions: Cognitive Impairment; Dementia
Interventions: Behavioral: Nutritional guidance; Behavioral: Exercise; Behavioral: Cognitive training; Other: Reduction of vascular risk factors
Sponsors: National Institute for Health and Welfare, Finland; National Institute for Health and Welfare, Finland; Academy of Finland; Helsinki University; University of Eastern Finland; University of Oulu; Kuopio Research Institute of Exercise Medicine; University of Western Ontario, Canada; Karolinska Institutet; Umeå University
Recruiting - verified August 2011 - Condition: Cognition Disorders
Interventions: Behavioral: Cognitive Strategy Training; Other: Placebo comparison group
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Delirium, Postoperative
Intervention:
Sponsors: Huazhong University of Science and Technology; Huazhong University of Science and Technology
Recruiting - verified September 2011 - Condition: Cognitive Dysfunction
Intervention: Other: Cognitive assessment
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified December 2009 - Conditions: Functional Disability; Dementia; Heart Disease; Stroke; Cancer; Bleeding
Interventions: Drug: 100 mg enteric-coated aspirin; Drug: Placebo
Sponsors: Minneapolis Medical Research Foundation; Minneapolis Medical Research Foundation; National Health and Medical Research Council, Australia; Bayer; Monash University; Berman Center for Outcomes and Clinical Research
Recruiting - verified July 2011 - Condition: Vascular Cognitive Impairment
Interventions: Behavioral: Aerobic-based exercise training; Behavioral: CON (control; usual care)
Sponsors: University of British Columbia; University of British Columbia; Canadian Stroke Network; Heart and Stroke Foundation of Canada
Recruiting - verified April 2012 - Conditions: Alzheimer's Disease; Dementia
Intervention: Drug: donepezil
Sponsors: Samsung Medical Center; Samsung Medical Center; Eisai Korea Inc.
Recruiting - verified July 2011 - Condition: Parkinson's Disease
Intervention: Drug: Donepezil
Sponsors: Newcastle-upon-Tyne Hospitals NHS Trust; Sharon Erb; University of Newcastle Upon-Tyne; University of Cambridge; University of Manchester; University of Birmingham; Bangor University; London School of Economics and Political Science; University College, London; Lancashire Care Trust; Institute for Ageing and Health, Newcastle University; King's College London
Not yet recruiting - verified November 2009 - Conditions: Dementia; Delirium
Intervention: Procedure: Orthogeriatric intervention
Sponsors: Oslo University Hospital; Ullevaal University Hospital; The Research Council of Norway
Recruiting - verified May 2012 - Conditions: Chronic Liver Disease; Minimal Hepatic Encephalopathy
Interventions: Drug: VSL#3; Drug: Lactulose
Sponsors: CD Pharma India Pvt. Ltd.; CD Pharma India Pvt. Ltd.; Indian Council of Medical Research; All India Institute of Medical Sciences, New Delhi
Recruiting - verified June 2011 - Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg; Drug: Bapineuzumab 1.0 m/kg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Disseminated Sclerosis
Intervention: Other: Cognitive impairment of multiple sclerosis
Sponsors: Nantes University Hospital; Nantes University Hospital
Recruiting - verified September 2009 - Conditions: Parkinson Disease; Huntington Disease
Intervention: Drug: [123I]MNI-420
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Condition: Alzheimer Disease
Intervention: Drug: ACC-001+ QS21
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Alzheimer Disease
Interventions: Drug: ACC-001+ QS21; Drug: ACC-001; Drug: ACC-001 + QS21
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Epigallocatechin-Gallate; Drug: Placebo
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified June 2011 - Condition: Memory Disorders
Intervention: Device: Deep brain stimulation
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified July 2009 - Condition: Hypoxic Ischaemic Encephalopathy
Intervention: Other: Xenon gas
Sponsors: Imperial College London; Imperial College London; University College London Hospitals; Guy's and St Thomas' NHS Foundation Trust
Recruiting - verified April 2012 - Condition: Cognitive Decline
Interventions: Drug: Lidocaine; Drug: Placebo
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); CAS Medical Systems, Inc.
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: memantine
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Condition: Parkinson's Disease
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified November 2011 - Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM; Other: Imaging with DATSCAN; Behavioral: neuropsychological evaluation
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Hepatic Encephalopathy
Interventions: Drug: Albumin; Drug: Sodium chloride 0.9%
Sponsors: Hospital Universitari Vall d'Hebron Research Institute; Hospital Universitari Vall d'Hebron Research Institute
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention: Procedure: Bilateral chronic electrical stimulation of the hypothalamus/fornix
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified April 2009 - Conditions: Alzheimer Disease; Dementia
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Alabama at Birmingham
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF; Procedure: Placebo Surgery
Sponsors: Ceregene; Ceregene; Alzheimer's Disease Cooperative Study (ADCS)
Recruiting - verified May 2012 - Conditions: Parkinson Disease; Huntington Disease; Autistic Spectrum Disorders; Fragile X Syndrome; Alzheimer Disease; Mild Cognitive Impairment
Intervention: Drug: (18F)FPEB
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute on Aging (NIA)
Recruiting - verified October 2011 - Conditions: Atrial Fibrillation; Post-Operative Delirium
Interventions: Drug: Lidocaine; Drug: Lidocaine; Other: Placebo
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified October 2011 - Conditions: Amyotrophic Lateral Sclerosis; Familial Amyotrophic Lateral Sclerosis; Amyotrophic Lateral Sclerosis With Frontotemporal Dementia; Lou Gehrig's Disease; Motor Neuron Disease; Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
Sponsors: Northwestern University; Northwestern University
Recruiting - verified July 2011 - Conditions: Alzheimer's Disease; Aphasia; Language Difficulties; Dementia
Intervention: Device: Repetitive Transcranial Magnetic Coil Stimulation (rTMS)
Sponsors: The New York Memory Services; The New York Memory Services
Recruiting - verified July 2011 - Conditions: Dementia; Alzheimer Disease; Dementia, Vascular; Sleep Disorders; Circadian Dysregulation
Interventions: Drug: Zolpidem CR; Drug: Zolpidem CR placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Conditions: Acute Kidney Injury; Post-Operative Delirium; Icu Delirium; Acute Renal Failure; Delirium
Interventions: Drug: atorvastatin; Drug: placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified July 2011 - Conditions: Hepatitis C, Chronic; Cognition Disorders; Fatigue Syndrome, Chronic; Major Depressive Disorder
Interventions: Drug: Interferon and ribavirin; Drug: Interferon Alfa-2a + ribavirin
Sponsors: University of Aarhus; Aarhus University Hospital
Recruiting - verified December 2011 - Condition: Otitis Media
Interventions: Drug: dexmedetomidine; Drug: saline
Sponsors: Ochsner Health System; Ochsner Health System
Recruiting - verified October 2011 - Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: Donepezil
Sponsors: Osaka University; Osaka University
Recruiting - verified December 2011 - Conditions: Cirrhosis; Acute on Chronic Hepatic Failure; Hepatorenal Syndrome; Encephalopathy
Intervention: Device: Single pass albumin dialysis
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Laboratoire français de Fractionnement et de Biotechnologies; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified December 2010 - Condition: Alzheimer's Disease
Interventions: Device: 1Hz TMS with H2 coil; Device: 10Hz TMS with H2 coil to prefrontal and parieto-temporal cortex; Device: SHAM TMS with H2 coil
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center; Brainsway
Recruiting - verified September 2011 - Conditions: Sickle Cell Disease; Thalassemia; Anemia; Granuloma; Wiskott-Aldrich Syndrome; Chediak Higashi Syndrome; Osteopetrosis; Neutropenia; Thrombocytopenia; Hurler Disease; Niemann-Pick Disease; Fucosidosis
Intervention: Procedure: Hematopoietic stem cell transplantation
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles
Recruiting - verified June 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease; Traumatic Brain Injury
Interventions: Behavioral: explicit memory training; Behavioral: implicit memory training
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Emory University
Recruiting - verified May 2012 - Condition: Huntington's Disease
Interventions: Drug: Creatine Monohydrate (HD-02); Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; University of Rochester; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified April 2012 - Condition: Cognitive Decline
Intervention:
Sponsors: Lahey Clinic; Lahey Clinic
Recruiting - verified February 2012 - Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab; Drug: bapineuzumab; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Huntington Disease
Interventions: Drug: Zyprexa; Drug: Xenazine; Drug: Tiapride
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified May 2011 - Conditions: Amnestic Mild Cognitive Impairment; Aging
Interventions: Behavioral: Recollection Training; Behavioral: Control
Sponsors: Baycrest; Baycrest
Recruiting - verified September 2011 - Conditions: Infant, Newborn; Hypoxia, Brain; Hypoxia-Ischemia, Brain; Encephalopathy, Hypoxic-Ischemic; Hypoxic-Ischemic Encephalopathy; Ischemic-Hypoxic Encephalopathy
Interventions: Procedure: Hypothermia; Procedure: Normothermic Control
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR)
Recruiting - verified September 2011 - Conditions: Frontotemporal Lobar Degeneration; Dementia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Condition: Huntington's Disease
Interventions: Drug: coenzyme Q10; Other: placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Neurological Disorders and Stroke (NINDS); University of Rochester
Recruiting - verified May 2012 - Condition: Cognitive Dysfunction
Interventions: Drug: iomazenil; Drug: iomazenil
Sponsors: Yale University; Yale University; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified May 2012 - Condition: Frontotemporal Lobar Degeneration
Intervention: Drug: Tolcapone
Sponsors: Columbia University; Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 2011 - Conditions: Hip Fractures; Delirium
Interventions: Device: Maintenance of level of awareness by use of a BIS monitor & the OASS.; Device: Maintenance of level of awareness by use of a BIS monitor and the OASS.
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH)
Recruiting - verified October 2011 - Condition: Neonatal Hypoxic Ischemic Encephalopathy
Interventions: Other: autologous cord blood; Other: no intervention
Sponsors: Duke University; Duke University
Recruiting - verified June 2011 - Conditions: Postoperative Delirium; PD; Postoperative Cognitive Dysfunction; POCD
Interventions: Drug: Precedex (Dexmedetomidine); Drug: Placebo
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; National Institute on Aging (NIA)
Recruiting - verified January 2012 - Condition: Primary Progressive Aphasia
Intervention:
Sponsors: Northwestern University; Northwestern University; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified April 2012 - Conditions: Delirium, Dementia, Amnestic, Cognitive Disorders; Age; Postoperative Complications; Memory Disorders
Intervention:
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified June 2011 - Conditions: Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear Palsy; Huntington Disease; Dystonia; Diffuse Lewy Body Disease
Intervention:
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France; European Union
Recruiting - verified December 2011 - Conditions: HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections; Healthy
Intervention: Drug: [11C]PBR28
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Conditions: Schizophrenia; Schizoaffective Disorder
Intervention: Drug: modafinil
Sponsors: University of California, Davis; University of California, Davis
Recruiting - verified August 2011 - Condition: Alzheimer's Disease
Intervention: Procedure: fMRI to detect MCI patients who will convert to Alzheimer's disease
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified April 2012 - Condition: Neimann-Pick Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Centers for Medicare and Medicaid Services
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Forest Laboratories; DSM Nutritional Products, Inc.
Recruiting - verified April 2012 - Condition: Huntington Disease
Intervention: Procedure: graft intracerebral of foetal neurons
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified March 2007 - Conditions: Alzheimer Disease; Late Onset Alzheimer Disease; Dementia
Intervention:
Sponsors: Indiana University; Indiana University; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Conditions: Epilepsy; Seizures; Cognition Disorders; Neuronal Migration Disorders
Intervention:
Sponsors: Harvard University Faculty of Medicine; Harvard University Faculty of Medicine; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified July 2011 - Conditions: Auditory Perceptual Disorder; Language Delay; Language Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified December 2011 - Conditions: Cognition Disorder; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2011 - Conditions: Cognition Disorder; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified June 2011
 |
Join Clinical trials for Delirium |
